跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 276 条关于
“mFolfirinox”
全部
276
临床试验
250
药物
2
机构
0
资讯
24
9个月前
PAXG Chemotherapy Shows Superior Event-Free Survival Over mFOLFIRINOX in Pancreatic Cancer Trial
10个月前
CASSANDRA Phase 3 Trial Shows PAXG Superior to mFOLFIRINOX in Preoperative Pancreatic Cancer Treatment
去年
Pelareorep Plus FOLFIRINOX Shows Acceptable Safety in Metastatic Pancreatic Cancer
去年
Oncolytics' Pelareorep Shows Promise in Pancreatic Cancer Trial, GOBLET Cohort 5 Enrollment Continues
去年
Oncolytics Biotech's Pelareorep Advances in Pancreatic Cancer Trial with Regulatory Approval
去年
NALIRIFOX Shows Numerically Improved Overall Survival Compared to FOLFIRINOX in Metastatic PDAC
去年
Gemcitabine-Capecitabine Adjuvant Therapy Prolongs Survival in Pancreatic Adenocarcinoma
去年
Alligator Bioscience to Present Biomarker Data from Promising Pancreatic Cancer Trial at ASCO 2025
去年
Oncolytics Biotech's Pelareorep Shows Promising Survival Benefit in Breast Cancer
去年
NCT/UCC Dresden Launches Phase 2 Trial of Personalized mRNA Vaccine for Pancreatic Cancer
第 1 页,共 3 页
上一页
下一页